Synergistic activity of combined NS5A inhibitors.
Wallingford, United States. In Antimicrob Agents Chemother, Jan 2016
UNASSIGNED: Daclatasvir (DCV) is a first in class hepatitis C virus (HCV) NS5A replication complex inhibitor (NS5A RCI) clinically effective in interferon-free combinations with direct acting antivirals (DAAs) targeting alternate HCV proteins.
Daddy, where did (PS)I come from?
Marseille, France. In Biochim Biophys Acta, 2001
The reacton centre I (RCI)-type photosystems from plants, cyano-, helio- and green sulphur bacteria are compared and the essential properties of an archetypal RCI are deduced.